Genetic overlap between idiopathic pulmonary fibrosis and COVID−19

Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long lasting respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterised by an aberrant response to alveola...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Richard J, Guillen-Guio, Beatriz, Croot, Emma, Kraven, Luke M, Moss, Samuel, Stewart, Iain, Jenkins, R Gisli, Wain, Louise V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130756/
https://www.ncbi.nlm.nih.gov/pubmed/35595312
http://dx.doi.org/10.1183/13993003.03132-2021
Descripción
Sumario:Coronavirus disease 2019 (COVID-19) is an infectious disease potentially leading to long lasting respiratory symptoms and has resulted in over 4 million deaths worldwide. Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial lung disease (ILD) characterised by an aberrant response to alveolar injury leading to progressive scarring of the lungs. Individuals with ILD are at a higher risk of death from COVID-19 [1].

Ejemplares similares